| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| BELLICUM PHARMACEUTICALS, INC | Chief Development Officer | Stock Option (right to buy) | 250K | $360K | $1.44 | Aug 15, 2022 | Direct |
| BELLICUM PHARMACEUTICALS, INC | Chief Development Officer | Common Stock | 14.6K | Dec 1, 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| BLCM | BELLICUM PHARMACEUTICALS, INC | Aug 15, 2022 | 1 | $360K | 4 | Aug 16, 2022 | Chief Development Officer |
| BLCM | BELLICUM PHARMACEUTICALS, INC | Dec 1, 2021 | 1 | $260K | 4 | Dec 2, 2021 | Chief Development Officer |
| BLCM | BELLICUM PHARMACEUTICALS, INC | Dec 1, 2021 | 0 | $0 | 3 | Dec 2, 2021 | Chief Development Officer |